Britain’s plan to raise NHS drug prices won’t bring back Lilly’s investment ⊕
found
a story from Politico EU ✅ › Politico EU
Comments from medicines firm Eli Lilly will be a blow to British officials, who are in advanced negotiations with the Trump administration to secure tariff relief.